Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming - Australian Snakebite Project (ASP-14)

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Allen, George E ^a   Brown, Simon G A ^b   Buckley, Nicholas A ^c,d   O'Leary, Margaret A ^e,f   Page, Colin B ^d,f,g   Currie, Bart J ^h   White, Julian ⁱ   Isbister, Geoffrey K ^d,e,f  

^a QUEEN ELIZABETH II JUBILEE HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d SYDNEY CHILDREN'S HOSPITAL   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

^h MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

ⁱ WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM ANTISERUM;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; AUSTRALIA; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CHILD; COLLAPSE; CONTROLLED STUDY; DEATH; DIAPHORESIS; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; ENVENOMATION; ENZYME IMMUNOASSAY; FEMALE; HEADACHE; HEART ARREST; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; NEUROTOXICITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSEUDONAJA; PSEUDONAJA TEXTILIS; PTOSIS; SCHOOL CHILD; SNAKE; SNAKEBITE; SYMPTOMATOLOGY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIVENINS; AUSTRALIA; CHILD; CHILD, PRESCHOOL; ELAPID VENOMS; ELAPIDAE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SNAKE BITES;

PSEUDONAJA; SERPENTES; STORERIA DEKAYI;

EID: 84871671439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053188     Document Type: Article

References (32)

1. Warrell DA, (2010) Snake bite. Lancet 375: 77-88.
2. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, et al. (2008) The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoSMed 5: e218.
3. Isbister GK, (2010) Antivenom efficacy or effectiveness: the Australian experience. Toxicology 268: 148-154.
4. Sutherland SK, Leonard RL, (1995) Snakebite deaths in Australia 1992-1994 and a management update. Medical Journal of Australia 163: 616-618.
5. Yeung JM, Little M, Murray LM, Jelinek GA, Daly FF, (2004) Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years. Medical Journal of Australia 181: 703-705.
6. Isbister GK, Brown SG, MacDonald E, White J, Currie BJ, (2008) Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Medical Journal of Australia 188: 473-476.
7. Isbister GK, O'Leary MA, Schneider JJ, Brown SG, Currie BJ, (2007) Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: In vivo and in vitro studies. Toxicon 49: 57-67.
8. White J (2001) CSL Antivenom Handbook. Melbourne: CSL Ltd.
9. Gan M, O'Leary MA, Brown SG, Jacoby T, Spain D, et al. (2009) Envenoming by the rough-scaled snake (Tropidechis carinatus): a series of confirmed cases. Medical Journal of Australia 191: 183-186.
10. Kulawickrama S, O'Leary MA, Hodgson WC, Brown SG, Jacoby T, et al. (2010) Development of a sensitive enzyme immunoassay for measuring taipan venom in serum. Toxicon 55: 1510-1518.
11. Currie BJ, (2004) Snakebite in tropical Australia: a prospective study in the "Top End" of the Northern Territory. Medical Journal of Australia 181: 693-697.
12. White J (2003) Elapid Envenomation. In: Covacevich J, Davie P, Pearn J, editors. Toxic Plants and Animals: A guide for Australia. Brisbane: Queensland Museum.
13. Jelinek GA, Breheny FX, (1990) Ten years of snake bites at Fremantle Hospital. Medical Journal of Australia 153: 658-661.
14. Henderson A, Baldwin LN, May C, (1993) Fatal brown snake (Pseudonaja textilis) envenomation despite the use of antivenom. Medical Journal of Australia 158: 709-710.
15. Currie BJ, (2000) Snakebite in tropical Australia, Papua New Guinea and Irian Jaya. Emergency Medicine 12: 285-294.
16. Jelinek GA, Hamilton T, Hirsch RL, (1991) Admissions for suspected snake bite to the Perth adult teaching hospitals, 1979 to 1988. Medical Journal of Australia 155: 761-764.
17. Isbister GK, White J, Currie BJ, O'Leary MA, Brown SG, (2011) Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12). Toxicon 58: 634-640.
18. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, et al. (2006) Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 117: 391-397.
19. Brown SG, (2004) Clinical features and severity grading of anaphylaxis. Journal of Allergy and Clinical Immunology 114: 371-376.
20. Skinner A, Donnellan SC, Hutchinson MN, Hutchinson RG, (2005) A phylogenetic analysis of Pseudonaja (Hydrophiinae, Elapidae, Serpentes) based on mitochondrial DNA sequences. Mol Phylogenet Evol 37: 558-571.
21. O'Leary MA, Isbister GK, (2009) Commercial monovalent antivenoms in Australia are polyvalent. Toxicon 54: 192-195.
22. Chaisakul J, Isbister GK, Konstantakopoulos N, Tare M, Parkington HC, et al. (2012) In vivo and in vitro cardiovascular effects of Papuan taipan (Oxyuranus scutellatus) venom: Exploring "sudden collapse". Toxicol Lett.
23. Isbister GK, (2010) Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Seminars in Thrombosis and Hemostasis 36: 444-451.
24. Barber CM, Isbister GK, Hodgson WC, (2012) Solving the 'Brown snake paradox': In vitro characterisation of Australasian snake presynaptic neurotoxin activity. Toxicol Lett 210: 318-323.
25. Birrell GW, Earl S, Masci PP, de Jersey J, Wallis TP, et al. (2006) Molecular diversity in venom from the Australian Brown snake, Pseudonaja textilis. MolCell Proteomics 5: 379-389.
26. Rao VS, Kini RM, (2002) Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: its structural and functional similarity to mammalian coagulation factor Xa-Va complex. ThrombHaemost 88: 611-619.
27. Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, et al. (2010) Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom. Toxicon 56: 75-85.
28. Kuruppu S, Smith AI, Isbister GK, Hodgson WC, (2008) Neurotoxins from Australo-Papuan elapids: a biochemical and pharmacological perspective. Crit RevToxicol 38: 73-86.
29. Sprivulis P, Jelinek GA, Marshall L, (1996) Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma. Anaesthesia and Intensive Care 24: 379-381.
30. Snakebite and Spiderbite Clinical Management Guidelines. (2007) In: Health, editor. Sydney: NSW Health.
31. Mirtschin PJ, Dunstan N, Hough B, Hamilton E, Klein S, et al. (2006) Venom yields from Australian and some other species of snakes. Ecotoxicology 15: 531-538.
32. Tibballs J, Sutherland S, (1991) The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species venom. Anaesthesia and Intensive Care 19: 530-534.